Alzheimer’s disease-associated complement gene variants influence plasma complement protein levels

被引:0
|
作者
Aurora Veteleanu
Joshua Stevenson-Hoare
Samuel Keat
Nikoleta Daskoulidou
Henrik Zetterberg
Amanda Heslegrave
Valentina Escott-Price
Julie Williams
Rebecca Sims
Wioleta M. Zelek
Sarah M. Carpanini
Bryan Paul Morgan
机构
[1] Cardiff University,UK Dementia Research Institute Cardiff, School of Medicine
[2] Cardiff University,Neurosciences and Mental Health Institute
[3] UK Dementia Research Institute at University College London,Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Psychology
[4] The Sahlgrenska Academy at the University of Gothenburg,Clinical Neurochemistry Laboratory
[5] Sahlgrenska University Hospital,Department of Neurodegenerative Disease
[6] UCL Institute of Neurology,Division of Psychological Medicine and Clinical Neurosciences
[7] Queen Square,undefined
[8] Hong Kong Center for Neurodegenerative Diseases,undefined
[9] Cardiff University,undefined
关键词
Alzheimer’s disease; Complement system; Biomarkers; Clusterin; Complement receptor 1; C1s; C1q; Factor H; GWAS;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Complement protein levels in plasma astrocyte-derived exosomes are abnormal in conversion from mild cognitive impairment to Alzheimer's disease dementia
    Winston, Charisse N.
    Goetzl, Edward J.
    Schwartz, Janice B.
    Elahi, Fanny M.
    Rissman, Robert A.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2019, 11 (01) : 61 - 66
  • [32] NEURODEGENERATIVE DISEASE Avoiding bad complement in Alzheimer's disease
    Flight, Monica Hoyos
    NATURE REVIEWS NEUROSCIENCE, 2009, 10 (09): : 623 - 623
  • [33] Complement Biomarkers as Predictors of Disease Progression in Alzheimer's Disease
    Hakobyan, Svetlana
    Harding, Katharine
    Aiyaz, Mohammed
    Hye, Abdul
    Dobson, Richard
    Baird, Alison
    Liu, Benjamine
    Harris, Claire Louise
    Lovestone, Simon
    Morgan, Bryan Paul
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 54 (02) : 707 - 716
  • [34] Hunting for biomarkers: The complement system in Alzheimer's disease
    Hakobyan, Svetlana
    Aiyaz, Mohammed
    Stretton, Alexandra
    Sattlecker, Martina
    Dobson, Richard
    Harris, Claire
    Morgan, Paul
    Lovestone, Simon
    IMMUNOBIOLOGY, 2012, 217 (11) : 1175 - 1175
  • [35] Complement activation by neurofibrillary tangles in Alzheimer's disease
    Shen, Y
    Lue, LF
    Yang, LB
    Roher, A
    Kuo, YM
    Strohmeyer, R
    Goux, WJ
    Lee, V
    Johnson, GVW
    Webster, SD
    Cooper, NR
    Bradt, B
    Rogers, J
    NEUROSCIENCE LETTERS, 2001, 305 (03) : 165 - 168
  • [36] Genetic Insights into the Impact of Complement in Alzheimer's Disease
    Torvell, Megan
    Carpanini, Sarah M.
    Daskoulidou, Nikoleta
    Byrne, Robert A. J.
    Sims, Rebecca
    Morgan, B. Paul
    GENES, 2021, 12 (12)
  • [37] The Role of Complement in Autoimmune Disease-Associated Thrombotic Microangiopathy and the Potential for Therapeutics
    Java, Anuja
    Kim, Alfred H. J.
    JOURNAL OF RHEUMATOLOGY, 2023, 50 (06) : 730 - 740
  • [38] Complement dysregulation and Alzheimer's disease in Down syndrome
    Veteleanu, Aurora
    Pape, Sarah
    Davies, Kate
    Kodosaki, Eleftheria
    Hye, Abdul
    Zelek, Wioleta M.
    Strydom, Andre
    Morgan, B. Paul
    ALZHEIMERS & DEMENTIA, 2023, 19 (04) : 1383 - 1392
  • [39] Activation of complement and contact system in Alzheimer's disease
    Bergamaschini, L
    Donarini, C
    Gobbo, G
    Parnetti, L
    Gallai, V
    MECHANISMS OF AGEING AND DEVELOPMENT, 2001, 122 (16) : 1971 - 1983
  • [40] Early complement components in Alzheimer's disease brains
    Veerhuis, R
    Janssen, I
    Hack, CE
    Eikelenboom, P
    ACTA NEUROPATHOLOGICA, 1996, 91 (01) : 53 - 60